97 related articles for article (PubMed ID: 1607150)
41. Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens.
Hayashi T; Morimoto C; Burks JS; Kerr C; Hauser SL
Ann Neurol; 1988 Oct; 24(4):523-31. PubMed ID: 3266456
[TBL] [Abstract][Full Text] [Related]
42. Transformation of ovarian dysgerminoma to yolk sac tumor: evidence for a histogenetic continuum.
Parkash V; Carcangiu ML
Mod Pathol; 1995 Oct; 8(8):881-7. PubMed ID: 8552580
[TBL] [Abstract][Full Text] [Related]
43. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
[TBL] [Abstract][Full Text] [Related]
45. Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.
Obiri NI; Siegel JP; Varricchio F; Puri RK
Clin Exp Immunol; 1994 Jan; 95(1):148-55. PubMed ID: 8287600
[TBL] [Abstract][Full Text] [Related]
46. An immunohistological examination of inflammatory cell infiltration in primary testicular seminomas.
Strutton GM; Gemmell E; Seymour GJ; Walsh MD; Lavin MF; Gardiner RA
Aust N Z J Surg; 1989 Feb; 59(2):169-72. PubMed ID: 2784051
[TBL] [Abstract][Full Text] [Related]
47. Expression of lymphotoxin-alpha by keratinocytes: a further mediator for the lichenoid reaction.
Middel P; Lippert U; Hummel KM; Bertsch HP; Artuc M; Schweyer S; Radzun HJ
Pathobiology; 2000; 68(6):291-300. PubMed ID: 11493763
[TBL] [Abstract][Full Text] [Related]
48. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Nouri AM; Symes MO
Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
[TBL] [Abstract][Full Text] [Related]
49. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis.
Illa I; Nath A; Dalakas M
Ann Neurol; 1991 May; 29(5):474-81. PubMed ID: 1859178
[TBL] [Abstract][Full Text] [Related]
50. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
51. The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review).
Zusman I; Gurevich P; Gurevich E; Ben-Hur H
Int J Oncol; 2001 May; 18(5):965-72. PubMed ID: 11295042
[TBL] [Abstract][Full Text] [Related]
52. Differential regulation of expression of the MHC class II molecules RT1.B and RT1.D on rat B lymphocytes: effects of interleukin-4, interleukin-13 and interferon-gamma.
Roos A; Schilder-Tol EJ; Chand MA; Claessen N; Lakkis FG; Pascual DW; Weening JJ; Aten J
Immunology; 1998 Jan; 93(1):33-40. PubMed ID: 9536116
[TBL] [Abstract][Full Text] [Related]
53. Malignant ovarian tumours during childhood.
Treuner J; Niethammer D; Schweizer P; Fischbach H; Flach A
Prog Pediatr Surg; 1983; 16():121-6. PubMed ID: 6348878
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical and topographic studies of dendritic cells and macrophages in human fetal cornea.
Diaz-Araya CM; Madigan MC; Provis JM; Penfold PL
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):644-56. PubMed ID: 7890495
[TBL] [Abstract][Full Text] [Related]
55. Endotoxin-induced uveitis. Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body.
McMenamin PG; Crewe J
Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):1949-59. PubMed ID: 7657537
[TBL] [Abstract][Full Text] [Related]
56. [The role of the structural characteristics of ovarian dysgerminoma in its prognosis].
Karseladze AI; Antoshechkina ET
Vopr Onkol; 1985; 31(4):60-6. PubMed ID: 4002671
[TBL] [Abstract][Full Text] [Related]
57. Ovarian dysgerminoma. A clinico-pathologic study.
Resta L; Sabatini R; Restaino A
Neoplasma; 1984; 31(4):459-64. PubMed ID: 6472517
[TBL] [Abstract][Full Text] [Related]
58. Ovarian dysgerminoma associated with fibrosarcoma: a case report.
Alvarado-Cabrero I; Valencia-Cedillo R; Mohs-Alfaro M; De Anda-González J
Int J Gynecol Pathol; 2011 Sep; 30(5):466-9. PubMed ID: 21804387
[TBL] [Abstract][Full Text] [Related]
59. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
60. [Peripheral blood T-cell subsets in patients with ovarian malignancies].
Liang LZ
Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):410-3. PubMed ID: 1981699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
